Assessing Patient Organization Participation in Health Policy: A Comparative Study in France and Italy

Kyriakos Souliotis ¹ * , Eirini Agapidaki ¹, Lily Evangelia Peppou ², Chara Tzavara ¹, Dimitrios Varvaras ³, Oreste Claudio Buonomo ³, Dominique Debiais ⁴, Stanimir Hasurdjiev ⁵, Francois Sarkozy ⁶

Cited by CrossRef:

1- Costa A, Oliveira M, Costa M, Morais K, Corrêa A, Wegner W, Burciaga L, Manzo B. Desafios e possibilidades de coparticipação da puérpera e do acompanhante no cuidado seguro. REME Rev Min Enferm. 2023;27 [Crossref]

2- Souliotis K, Peppou L, Agapidaki E, Tzavara C, Debiais D, Hasurdjiev S, Sarkozy F. Health democracy in Europe: Cancer patient organization participation in health policy. Health Expectations. 2018;21(2):474 [Crossref]

3- Albuquerque A, Soares Neto J. Organizações de pacientes e seu papel na implementação de direitos nos cuidados em saúde. Cad Ibero Am Direito Sanit. 2022;11(1):144 [Crossref]

4- Morais T. Ensaio sobre a análise bioética do mecanismo da Perspectiva do Paciente da Conitec sob a ótica do referencial dos Direitos Humanos do Paciente. bis. 2024;25(2):117 [Crossref]

5- Albuquerque A. Direito do Paciente: fundamentos teóricos do novo ramo jurídico. RDyS. 2022;6(7):47 [Crossref]

6- Jakovljevic M, Groot W, Souliotis K. Editorial: Health care financing and affordability in the emerging global markets, Volume II. Front Public Health. 2022;10 [Crossref]

7- Gavaruzzi T. Where are we in shared decision-making in Italy? A brief updated review. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen. 2022;171:74 [Crossref]

8- Hilverda F, Tielens K, Petit-Steeghs V. Youth patient and public involvement in health research in the Netherlands: experiences from a multi-stakeholder interview study. Res Involv Engagem. 2025;11(1) [Crossref]

9- Huang R, Wei Y, Hu J, Kong F, He J, Yang Y, Tang M, Jin C, Kang Q. The progress of, challenges faced by, and future of rare disease patient organizations in China. IRDR. 2019;8(2):158 [Crossref]

10- Nikiphorou E, Santos E, Marques A, Böhm P, Bijlsma J, Daien C, Esbensen B, Ferreira R, Fragoulis G, Holmes P, McBain H, Metsios G, Moe R, Stamm T, de Thurah A, Zabalan C, Carmona L, Bosworth A. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Annals of the Rheumatic Diseases. 2021;80(10):1278 [Crossref]

11- Fleck J, Pereira R, Silva A, Gimenes F. Adherence to safety barriers in medication administration: patients’ perception. Rev Latino-Am Enfermagem. 2021;29 [Crossref]

12- Tandwa L, Dhai A. Public engagement in the development of the National Health Insurance: a study involving patients from a central hospital in South Africa. BMC Public Health. 2020;20(1) [Crossref]

13- Iosa M, Galeoto G, De Bartolo D, Russo V, Ruotolo I, Spitoni G, Ciancarelli I, Tramontano M, Antonucci G, Paolucci S, Morone G. Italian Version of the Pittsburgh Rehabilitation Participation Scale: Psychometric Analysis of Validity and Reliability. Brain Sciences. 2021;11(5):626 [Crossref]

14- Gathen J, Slettebø T, Skjeggestad E. Three strategies of user participation. Interest organisation representatives’ views on how they make an impact on service development. Nordic Social Work Research. 2023;:1 [Crossref]

15- Saadati F, Nadrian H, Golkar M, Taghdisi M, Gilani N, Ghassab-Abdollahi N, Fathifar Z. Indices and Indicators Developed to Evaluate the “Strengthening Community Actions” Mechanism of the Ottawa Charter for Health Promotion: A Scoping Review. Am J Health Promot. 2022;36(5):881 [Crossref]

16- Wallraf S, Köthemann S, Wiesemann C, Wöhlke S, Dierks M, Schmidt M, van Gils-Schmidt H, Lander J. Digital Transformation in Patient Organizations: Interview and Focus Group Study. J Med Internet Res. 2025;27:e62750 [Crossref]

17- Oliveira T, Diniz C, Carvalho M, Corrêa A, Rocha P, Manzo B. Involvement of companions in patient safety in pediatric and neonatal units: scope review. Rev Bras Enferm. 2022;75(3) [Crossref]

18- Zigdon A, Eckhaus E, Rosenfeld M, Zigdon O. Chronically ill patients’ perspectives on support services and activities of patient organizations. Isr J Health Policy Res. 2024;13(1) [Crossref]

19- Souliotis K, Peppou L, Tzavara C, Agapidaki E, Varvaras D, Buonomo O, Debiais D, Hasurdjiev S, Sarkozy F. Cancer patients’ organisation participation in heath policy decision-making: a snapshot/cluster analysis of the EU-28 countries. BMJ Open. 2018;8(8):e018896 [Crossref]

20- Spriņģe L, Stars I, Kursīte M, Putniņa R, Ķīvīte-Urtāne A, Villeruša A, Vilka L, Krumina J. The response of patient organizations to the first phase of the COVID-19 pandemic: A qualitative study in Latvia. SHS Web Conf. 2024;184:02007 [Crossref]

21- Ferhatbegović L, Mršić D, Kušljugić S, Pojskić B. LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated?. Curr Atheroscler Rep. 2022;24(8):635 [Crossref]

22- Fredriksson M, Modigh A. Patient involvement at the managerial level: the effectiveness of a patient and family advisory council at a regional cancer centre in Sweden. BMC Health Serv Res. 2021;21(1) [Crossref]

23- Suarez‐Herrera J, Diaz‐Castro L, Ramirez‐Rojas M, Pelcastre‐Villafuerte B. Unpacking participation in healthcare governance: Lessons from two local health councils in Brazil and Spain. Health Planning & Management. 2024;39(4):1097 [Crossref]

Submit Your Paper Archive